ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Other Cardiometabolic Health medicines by Quarter
Other Cardiometabolic Health medicines — Outside U.S. revenue ($M) ($M)
Eli Lilly Other Cardiometabolic Health medicines: $477M in Q2 2026, up 12.2% from a year earlier.
Latest, Q2 2026
477
Period ended Jun 30, 2026
Change on a year earlier
+12.2%
425 in Q2 2025
History
13 quarters
Since Q2 2023
Sources
8
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Note 2.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Cardiometabolic Health medicines — Outside U.S. revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 477 | +12.2% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 460 | +12.2% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 492 | -0.8% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 446 | +0.1% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 425 | +3.2% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 410 | -3.3% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 496 | -65.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 446 | +402.8% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 412 | +349.5% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 424 | – | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,454 | – | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 88.6 | – | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2023 | Jun 30, 2023 | 91.6 | – | Form 10-Q (filed 2024-08-08) ↗ |
Cite this data
StockData. (2026). Eli Lilly Other Cardiometabolic Health medicines ($M), quarterly Q2 2023–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-other-cm-nonus
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.